Efectividad de belimumab en el tratamiento de la nefritis lúpica: análisis de 8 casos

Kaul, 2016, Systemic lupus erythematosus, Nat Rev Dis Primers, 2, 16039, 10.1038/nrdp.2016.39 Basta, 2020, Systemic lupus erythematosus (SLE) Therapy: The old and the new, Rheumatol Ther, 7, 433, 10.1007/s40744-020-00212-9 Cassia, 2017, Lupus nephritis and B-cell targeting therapy, Expert Rev Clin Immunol, 13, 951, 10.1080/1744666X.2017.1366855 Ward, 2020, Belimumab as add-on therapy in lupus nephritis, N Engl J Med, 383, 1184, 10.1056/NEJMe2027516 Ruiz-Irastorza, 2020, Treating systemic lupus erythematosus in the 21st century: New drugs and new perspectives on old drugs, Rheumatology (Oxford), 59, v69, 10.1093/rheumatology/keaa403 Blair, 2018, Belimumab: A review in systemic lupus erythematosus, Drugs, 78, 355, 10.1007/s40265-018-0872-z Furie, 2020, Two-year, randomized, controlled trial of belimumab in lupus nephritis, N Engl J Med, 383, 1117, 10.1056/NEJMoa2001180 Sciascia, 2017, Efficacy of belimumab on renal outcomes in patients with systemic lupus erythematosus: A systematic review, Autoimmun Rev, 16, 287, 10.1016/j.autrev.2017.01.010 Binda, 2020, Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient), J Nephrol, 33, 1019, 10.1007/s40620-020-00706-3